New figures spotlight fall in foreign investment and failure to innovate via NHS
The UK is failing to take advantage of its strength in biomedical research and innovation, the nation’s pharma industry association has warned in response to figures showing a fall in foreign investment.
The Association for the British Pharmaceutical Industry was responding to the government Office for Life Science’s publication of its statistics analysis, Life Sciences Competitiveness Indicators 2024.